There are over 7000 rare diseases, some affecting 3500 or fewer patients in the United States. Due to clinicians’ limited experience with such diseases and the heterogeneity of clinical presentations, ~70% of individuals seeking…
Continue Reading
Pangea Data, a company focused on detecting rare diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for…
Continue Reading
Pangaea Data, a company focused on detecting hard-to-diagnose diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for an…
Continue Reading
The Evolving Orphan Drug Landscape
Once considered specialized treatments for rare conditions, orphan drugs are now challenging the dominance of mainstream medications in the pharmaceutical industry. According to two recent Evaluate reports—”Are Orphans That Different?”…
Rare diseases, affecting ~350 million people worldwide, pose significant challenges in clinical diagnosis due to the lack of experienced physicians and the complexity of differentiating between numerous rare diseases. To address these challenges, we…
Continue Reading
Korea officially launches big bio data projectThe South Korean government has started recruiting participants for the National Integrated Bio Big Data Construction Project.
The ambitious 606 billion won (over $400 million) project is Korea’s largest healthcare project…
Unite Genomics announced a new clinical listening partnership with a “Top 10 pharma company” that can personalize and tailor patient psoriasis care insights based on their medical records on Monday.This direct-to-consumer platform uses artificial…
Continue Reading
Patients with rare diseases often experience prolonged diagnostic delays. Ordering appropriate genetic tests is crucial yet challenging, especially for general pediatricians without genetic expertise. Recent American College of Medical Genetics (ACMG) guidelines embrace early…
Continue Reading
Citizen Health, a company that helps patients oversee rare and complex health conditions, announced it raised $14.5 million in seed funding.Transformation Capital led the round with participation from Wavemaker 360 and prominent angel investors.
The…
What You Should Know:
– Citizen Health, an innovative AI-powered consumer health platform designed to support over 400 million individuals managing rare and complex conditions, has announced the successful closing of a $14.5 million seed round.
– The…
Continue Reading
